跳至主要内容
临床试验/DRKS00021024
DRKS00021024招募中不适用

Register for Cardiovascular Events under new cancer Therapies - RECENT

niversitätsklinikum KölnKlinik III für Innere Medizin0 个研究点目标入组 200 人开始时间: 2021年11月19日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Patients prior to initiation of a therapy with a checkpoint inhibitor for the treatment of a malignant disease
  • Patients prior to initiation of a therapy or under therapy with a BTK inhibitor for the treatment of a malignant disease
  • Patients prior to initiation of a therapy with the combination of BRAF and MEK inhibitors for the treatment of a malignant disease
  • Age> 18 years
  • Educational ability: The patient must be able to understand and to sign the declaration of consent. He must be sufficiently proficient in the German language.

排除标准

  • Lack of consent
  • Pregnant or breastfeeding women
  • Patient depending on or in relation to the sponsor or PI
  • Life expectancy <12 months due to illness
  • Patients unable to give informed consent

研究者

发起方
niversitätsklinikum KölnKlinik III für Innere Medizin

相似试验